默克尔细胞癌辅助放疗启动时间对生存的影响:基于国家癌症数据库的分析
本研究基于国家癌症数据库,纳入2006至2014年诊断的2293例I或II期默克尔细胞癌患者,分析手术切除至辅助放疗启动时间(TTI)对总生存(OS)的影响。多因素Cox建模显示TTI与OS无关(P=0.19)。结论认为术后180天内启动辅助放疗的TTI延长未显示与OS相关,但仍应尽量减少不必要的辅助治疗延迟。
要点
- 2293例I或II期默克尔细胞癌患者中位TTI为62天(四分位距43-86天)。
- 多因素Cox建模显示TTI与总生存无关(P=0.19)。
- 结论认为术后180天内TTI延长未显示生存损害,但仍应尽量减少不必要的辅助治疗延迟。
核心结论
- 在国家癌症数据库的该分析中,I或II期默克尔细胞癌患者辅助放疗TTI延长与总生存无关。
- 本研究中位TTI为62天,为全国层面TTI提供了背景参考,或可给术后伤口愈合延长或并发疾病延迟立即放疗的患者带来 reassurance。
- 尽管术后180天内TTI延长未显示明确的生存损害,仍应继续尽量减少不必要的辅助治疗启动延迟,同时确保切除后最佳恢复。
研究设计与样本
- 查询国家癌症数据库,纳入2006至2014年诊断的头颈部、躯干或四肢默克尔细胞癌患者。
- 排除未行切除或术后180天内未接受辅助放疗者,共2293例纳入分析。
- TTI定义为切除至首次放疗分次的时间,采用线性回归、递归分割分析和Cox比例风险建模。
主要发现
- 队列中位TTI为62天(四分位距43-86天)。
- 多因素Cox建模显示TTI与总生存无关(P=0.19)。
- 与TTI相关的因素包括年龄、治疗机构类型、淋巴结检查、解剖亚部位和手术切缘(P<0.05)。
- 与OS相关的因素包括年龄、性别、保险状态、Charlson-Deyo合并症评分、淋巴结检查状态、肿瘤大小和手术切缘(均P<0.05)。
临床怎么用
- 原文结论认为术后180天内TTI延长未显示明确的生存损害,但仍应继续尽量减少不必要的辅助治疗启动延迟,同时确保切除后最佳恢复。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to determine the impact of time to initiation (TTI) of adjuvant radiation therapy (RT) on overall survival (OS) for patients with stage I or II Merkel cell carcinoma (MCC). METHODS AND MATERIALS: The National Cancer Database was queried for patients with MCC of the head and neck, trunk, or extremities diagnosed between 2006 and 2014. Patients who did not undergo resection or receive adjuvant RT within 180 days of surgery were excluded. TTI was defined as the time from resection to first RT fraction. Linear regression was used to define factors associated with TTI. Recursive partitioning analysis modeling was performed to determine an optimal threshold for TTI. Cox proportional hazards modeling was performed to define covariates associated with OS. RESULTS: A total of 2293 patients were included in this study. The median TTI for the cohort was 62 days (interquartile range, 43-86 days). TTI was not associated with OS for the overall cohort by multivariable Cox modeling (P = .19). Age, treatment facility type, lymph node examination, anatomic subsite, and surgical margin were associated with TTI (P < .05). Age, sex, insurance status, Charlson-Deyo comorbidity score, lymph node examination status, tumor size, and surgical margin were associated with OS (all P < .05). CONCLUSIONS: Increased TTI of adjuvant RT was not associated with OS for patients with early stage MCC in this analysis of the National Cancer Database. The median TTI of 62 days from resection to adjuvant RT initiation for our study cohort contextualizes TTI on a national level and may offer reassurance for patients with prolonged postoperative wound healing or intercurrent illness delaying immediate RT initiation. Despite the lack of a clear detriment to survival with increased TTI up to 180 days from surgery, unnecessary delays in initiating adjuvant therapy should continue to be minimized while ensuring optimal recovery from resection.
引用
- Yusuf M, Gaskins J, Tennant P, et al. Survival Impact of Time to Initiation of Adjuvant Radiation for Merkel Cell Carcinoma: An Analysis of the National Cancer Database. Pract Radiat Oncol. 2019. PMID: 30926480. doi:10.1016/j.prro.2019.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。